Taysha’s GAN Gene Therapy Hits FDA Speedbump

Submitted by admin on February 1, 2023 - 10:35am

Source:

BioSpace

News Tags:

Taysha Gene Therapies

TSHA-120

axonal neuropathy

clinical trials

gene therapy

FDA

Headline:

Taysha’s GAN Gene Therapy Hits FDA Speedbump

snippet:

The FDA asked Taysha Gene Therapies to dose more patients in a double-blinded, placebo-controlled trial for its Biological License Application for its giant axonal neuropathy (GAN) candidate TSHA-120, the company announced Tuesday.

Search form

You are here

Taysha’s GAN Gene Therapy Hits FDA Speedbump

Taysha’s GAN Gene Therapy Hits FDA Speedbump